Effects of risankizumab on nail psoriasis in patients with active psoriatic arthritis: results from KEEPsAKE 1

J Eur Acad Dermatol Venereol. 2022 May;36(5):e389-e392. doi: 10.1111/jdv.17931. Epub 2022 Jan 28.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Monoclonal / therapeutic use
  • Arthritis, Psoriatic* / complications
  • Arthritis, Psoriatic* / drug therapy
  • Humans
  • Nail Diseases* / drug therapy
  • Nails, Malformed*
  • Psoriasis* / complications
  • Psoriasis* / drug therapy

Substances

  • Antibodies, Monoclonal
  • risankizumab

Grants and funding